BD
Bhashker Dabral
About Bhashker Dabral
Data last updated:
Bhashker Dabral is a Director at Acies Pharmaceutical Private Limited (since 2019) and Director at Alexon Healthcare Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹39.73 Cr; the largest is Acies Pharmaceutical Private Limited at ₹37.03 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Apr 2019 | 2019 | ₹37.03 Cr (FY 2025) | Active | |
| Director | 03 Nov 2023 | 2022 | ₹2.70 Cr (FY 2024) | Active |
Board colleagues of Bhashker Dabral
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sujata Dabral | 08426753 | Acies Pharmaceutical Private Limited , Alexon Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhashker Dabral
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhashker Dabral
Bhashker Dabral currently holds 2 directorships: Acies Pharmaceutical Private Limited (Director, since 19 Apr 2019, revenue ₹37.03 Cr (FY 2025)); Alexon Healthcare Private Limited (Director, since 03 Nov 2023, revenue ₹2.70 Cr (FY 2024)).
Bhashker Dabral was first appointed on 19 Apr 2019 as Director at Acies Pharmaceutical Private Limited. The most recent appointment on record is 03 Nov 2023 at Alexon Healthcare Private Limited.
The 2 current companies of Bhashker Dabral that report revenue have a combined latest revenue of ₹39.73 Cr: Acies Pharmaceutical Private Limited ₹37.03 Cr (FY 2025); Alexon Healthcare Private Limited ₹2.70 Cr (FY 2024).
The current boards of Bhashker Dabral's companies include Sujata Dabral (Acies Pharmaceutical Private Limited).